| Literature DB >> 24808895 |
Eamonn P Culligan1, Julian R Marchesi2, Colin Hill1, Roy D Sleator3.
Abstract
In the current study, a number of salt-tolerant clones previously isolated from a human gut metagenomic library were screened using Phenotype MicroArray (PM) technology to assess their functional capacity. PM's can be used to study gene function, pathogenicity, metabolic capacity and identify drug targets using a series of specialized microtitre plate assays, where each well of the microtitre plate contains a different set of conditions and tests a different phenotype. Cellular respiration is monitored colorimetrically by the reduction of a tetrazolium dye. One clone, SMG 9, was found to be positive for utilization/transport of L-carnitine (a well-characterized osmoprotectant) in the presence of 6% w/v sodium chloride (NaCl). Subsequent experiments revealed a significant growth advantage in minimal media containing NaCl and L-carnitine. Fosmid sequencing revealed putative candidate genes responsible for the phenotype. Subsequent cloning of two genes did not replicate the L-carnitine-associated phenotype, although one of the genes, a σ(54)-dependent transcriptional regulator, did confer salt tolerance to Escherichia coli when expressed in isolation. The original clone, SMG 9, was subsequently found to have lost the original observed phenotype upon further investigation. Nevertheless, this study demonstrates the usefulness of a phenomic approach to assign a functional role to metagenome-derived clones.Entities:
Keywords: BIOLOG; functional metagenomics; gut microbiome; metagenomics; microbiota; phenotype microarray; salt tolerance; transcriptional regulator
Year: 2014 PMID: 24808895 PMCID: PMC4010731 DOI: 10.3389/fmicb.2014.00189
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Overview of the study design using combined functional metagenomic and phenomic approaches. An overview of the study design and experimental process incorporating metagenomic library creation and screening, identification of salt tolerant clones, comparison of clone to control strain using Phenotypic Microarray (PM) assay and further analyses that may be performed to identify novel genes.
Bacterial strains, plasmids and oligonucleotide primers used in this study.
| F− | Epicentre Biotechnologies, Madison, WI, USA | |
| MC4100 | Haardt et al., | |
| MKH13 containing pCI372 with | This study | |
| MKH13 containing pCI372 with | This study | |
| EPI300 containing pCI372 with | This study | |
| EPI300 containing pCI372 with | This study | |
| pCI372 | Shuttle vector between | Hayes et al., |
| pCC1FOS | Fosmid cloning vector, Cm | Epicentre Biotechnologies, Madison, WI, USA |
| pCI372 FP | CGGGAAGCTAGAGTAAGTAG | This study |
| pCI372 RP | CCTCTCGGTTATGAGTTAG | This study |
| AAAA | This study | |
| GC | This study | |
| AAAA | This study | |
| GC | This study | |
FP, forward primer; RP, reverse primer; CmR, chlorpamphenicol resistance; Restriction enzyme cut sites are underlined; PstI, CTGCAG; XbaI, TCTAGA; SalI, GTCGAC.
Figure 2Appearance of PM 9 plates after incubation for 24 hours at 37°C. (A) Control EPI300::pCC1FOS and (B) SMG 9. PM plates measure cellular respiration colorimetrically via reduction of a tetrazolium dye with electrons from NADH generated during the process of respiration. Strongly metabolized substrates generate a more intense purple color. Development of a strong purple color can be seen in well B12 in Figure 2B (circled in red), which was inoculated with SMG 9, while no color development is visible in B12 of the control plate. This indicates SMG 9 has a greater ability to transport and utilise L-carnitine compared to the EPI300::pCC1FOS host strain.
Figure 3Kinetic data measured by BIOLOG Omnilog system. Color formation within each well was measured by BIOLOG's Omnilog machine, which produces a color coded graph. Kinetic data from two clones can be compared. EPI300::pCC1FOS is shown in red and that from SMG 9 is shown in green. The green color indicates more rapid metabolism by SMG 9 under the conditions in the well (6% NaCl + L-carnitine).
Figure 4Growth in M9 minimal media with NaCl +/− 1mM L-carnitine. Growth of E. coli EPI300::pCC1FOS and SMG 9 in (A) M9 minimal media, (B) M9 minimal media + 4% NaCl, (C) M9 minimal media + 5% NaCl and (D) M9 minimal media + 6% NaCl. Legend: E. coli EPI300::pCC1FOS (• closed circle); SMG 9 (▽ open triangle); E. coli EPI300::pCC1FOS + 1mM L-carnitine (■ closed square); SMG 9 + 1 mM L-carnitine, (◊ open diamond).
Proteins predicted to be encoded on SMG 9 fosmid insert.
| 1 | ATP-dependent chaperone ClpB | 554 | 97 | 0.00E + 00 | 99 | COG0714; AAA ATPase | |
| 2 | Preprotein translocase SecG subunit | 121 | 100 | 3.00E-77 | 100 | SecG | |
| 3 | Putative uncharacterized protein | 187 | 100 | 3.00E-134 | 100 | None detected | |
| 4 | Putative uncharacterized protein | 177 | 86 | 3.00E-108 | 99 | LptE | |
| 5 | Transcriptional regulator | 432 | 100 | 0.00E + 00 | 99 | AAA ATPase; σ 54 interaction domain; HTH_8 bacterial reg protein, Fis family domain | |
| 6 | Putative uncharacterized protein | 545 | 100 | 0.00E + 00 | 99 | TadD | |
| 7 | Putative uncharacterized protein | 1015 | 100 | 0.00E + 00 | 99 | SecD, SecF | |
| 8 | OmpA/MotB domain protein | 618 | 71 | 0.00E + 00 | 99 | PD40, similar to WD40 domain | |
| 9 | Putative uncharacterized protein | 155 | 100 | 4.00E-106 | 100 | NfeD | |
| 10 | uPF0365 protein AL1_06760 | 317 | 100 | 0.00E + 00 | 99 | YdfA_immunity superfamily | |
| 11 | Putative uncharacterized protein | 142 | 100 | 1.00E-97 | 98 | Lipocalin_4 | |
| 12 | Subtilisin-like serine protease | 678 | 100 | 0.00E + 00 | 99 | Peptidase_S8_S53 superfamily | |
| 13 | Uncharacterized protein | 812 | 99 | 0.00E + 00 | 99 | None detected | |
| 14 | RagB/SusD family protein | 547 | 100 | 0.00E + 00 | 99 | Two SusD superfamily | |
| 15 | Outer membrane receptor for ferrienterochelin and colicins | 1068 | 100 | 0.00E + 00 | 100 | Can_B2; Plug; OM channel; OMP_RagA_SusC | |
| 16 | Alpha-L-fucosidase-like | 513 | 100 | 0.00E + 00 | 98 | COG3669; Alpha_L_fucos; F5_F8_Type_C | |
| 17 | Putative uncharacterized protein | 446 | 100 | 0.00E + 00 | 99 | DHQ_FE-ADH (Dehydroquinate iron aldehyde dehydrogenase) | |
| 18 | Major facilitator superfamily MFS_1 | 487 | 100 | 0.00E + 00 | 100 | MFS; UhpC, sugar phosphate permease | |
| 19 | ThiF family protein | 242 | 100 | 4.00E-174 | 98 | YgdL_like | |
| 20 | Putative uncharacterized protein | 649 | 100 | 0.00E + 00 | 98 | Glyco_hydro_97 | |
| 21 | DNA mismatch repair protein MutS | 894 | 98 | 0.00E + 00 | 99 | PRK05399; MutS-I; MutS_II; MutS_III; ABC_MutS_1 | |
| 22 | Glycosyl transferase group 1 | 378 | 100 | 0.00E + 00 | 99 | RfaG | |
| 23 | No significant similarity found | 68 | N/A | N/A | N/A | N/A | N/A |
| 24 | Hypothetical protein Fjoh_3657 | 162 | 80 | 4.00E-25 | 40 | AdkA, archaeal adenylate kinase |
Functional assignment is based on BLASTP of amino acid sequences predicted by Softberry's FGENESB. Abbreviations: # a.a, number of predicted amino acids; %ID, % identity at the amino acid level; N/A, not applicable.
Figure 5Growth in LB broth with NaCl. Growth in of E. coli MKH13::pCI372 (• black circle) and MKH13::pCI372-sdtR (▽ open triangle) in (A) LB broth and LB broth supplemented with (B) 2% NaCl, (C) 3% NaCl and (D) 4% NaCl.
Figure 6Growth in M9 minimal media with NaCl +/− L-carnitine. Growth of EPI300::pCI372 and EPI300::pCI372-sdtR in (A) M9 minimal media and (B) M9 minimal media + 6% NaCl. Legend: E. coli EPI300::pCI372 (• black circle); EPI300::pCI372 + 1 mM L-carnitine (▽ open triangle); EPI300::pCI372-sdtR (■ closed square); EPI300::pCI372-sdtR + 1mM L-carnitine, (◊ open diamond).